Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

4.7K Views

07:42 min

February 7th, 2021

DOI :

10.3791/62130-v

February 7th, 2021


Przeglądaj więcej filmów

Patient derived Tumor Explants

Rozdziały w tym wideo

0:04

Introduction

0:45

Explant Preparation and Drug Treatment

2:12

Histological Processing

3:09

Training Analysis

6:04

Results: Representative Patient-Derived Explant Responses to Tumor Drugs of Interest

7:02

Conclusion

Powiązane Filmy

article

09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

13.5K Views

article

09:53

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

12.0K Views

article

09:56

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

9.0K Views

article

12:12

Enhanced Viability for Ex vivo 3D Hydrogel Cultures of Patient-Derived Xenografts in a Perfused Microfluidic Platform

6.0K Views

article

09:50

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

7.9K Views

article

06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

5.1K Views

article

06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

1.6K Views

article

05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

1.3K Views

article

09:13

Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer

825 Views

article

05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

704 Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone